import { GuideLayout } from "@/components/guides/GuideLayout";
import { QuickAnswerBox } from "@/components/guides/QuickAnswerBox";
import { BottomLineBox } from "@/components/guides/BottomLineBox";
import { GuideFAQ } from "@/components/guides/GuideFAQ";
import { GuideCTA } from "@/components/guides/GuideCTA";
import { GuideDisclaimer } from "@/components/guides/GuideDisclaimer";
import { RelatedGuides } from "@/components/guides/RelatedGuides";
import { GuideTableOfContents } from "@/components/guides/GuideTableOfContents";
import { SITE_URL } from "@/lib/seo";

const tocItems = [
  { id: "what-is-tb500", title: "What Is TB-500?", level: 2 },
  { id: "mechanism", title: "Mechanism of Action", level: 2 },
  { id: "animal-studies", title: "Animal Studies on Tendon Repair", level: 2 },
  { id: "human-evidence", title: "Human Evidence (None)", level: 2 },
  { id: "vs-bpc157", title: "TB-500 vs BPC-157 for Tendons", level: 2 },
  { id: "legal-status", title: "Legal Status", level: 2 },
  { id: "primary-sources", title: "Primary Sources", level: 2 },
  { id: "faq", title: "FAQ", level: 2 },
];

const faqItems = [
  { question: "How long does TB-500 take to work?", answer: "There is no established timeline because no human clinical trials exist. Animal studies showed effects over weeks. Anecdotal reports suggest several weeks to months. Without human data, any timeline is speculation." },
  { question: "Is TB-500 better than BPC-157 for tendons?", answer: "This cannot be answered scientifically. Neither has human clinical trials for tendon repair. They work through different mechanisms. Comparing efficacy is impossible without proper research." },
  { question: "Can TB-500 heal a torn ligament?", answer: "There is no evidence TB-500 heals human ligaments. Animal studies show tissue repair effects, but these don't prove human efficacy. Ligament injuries require proper medical evaluation and treatment." },
];

const relatedGuides = [
  { title: "TB-500 vs BPC-157", href: "/guides/tb-500-vs-bpc-157" },
  { title: "BPC-157 for Tendonitis", href: "/guides/bpc-157-tendonitis" },
  { title: "Are Peptides Safe?", href: "/guides/are-peptides-safe" },
];

const articleSchema = { "@context": "https://schema.org", "@type": "Article", headline: "TB-500 for Tendon Repair: Research Evidence [2026]", description: "Evidence-based analysis of TB-500 (Thymosin Beta-4) for tendon repair. Animal research, mechanism, and why there's no human evidence.", datePublished: "2026-02-02", dateModified: "2026-02-02", author: { "@type": "Organization", name: "Peptide Playbook" }, publisher: { "@type": "Organization", name: "Peptide Playbook", logo: { "@type": "ImageObject", url: `${SITE_URL}/logo.png` } }, mainEntityOfPage: { "@type": "WebPage", "@id": `${SITE_URL}/guides/tb-500-tendon-repair` } };

const faqSchema = { "@context": "https://schema.org", "@type": "FAQPage", mainEntity: faqItems.map((item) => ({ "@type": "Question", name: item.question, acceptedAnswer: { "@type": "Answer", text: item.answer } })) };

export default function TB500TendonRepair() {
  return (
    <GuideLayout title="TB-500 for Tendon Repair: Research Evidence [2026]" description="Evidence-based analysis of TB-500 (Thymosin Beta-4) for tendon repair. Animal research, mechanism, and why there's no human evidence." slug="tb-500-tendon-repair" articleSchema={articleSchema} faqSchema={faqSchema}>
      <div className="flex gap-10">
        <GuideTableOfContents items={tocItems} />
        <article className="flex-1 max-w-3xl">
          <QuickAnswerBox answer="TB-500 (Thymosin Beta-4) has shown tissue repair effects in animal models, including some tendon studies. The mechanism involves actin regulation and cell migration. However, there are no published human clinical trials on TB-500 for tendon injuries. It's FDA Category 2 (cannot be compounded) and WADA banned." lastUpdated="February 2, 2026" readTime="7 minutes" />
          <h1 className="text-3xl md:text-4xl font-bold mb-8">TB-500 for Tendon Repair: Research Evidence</h1>
          <section id="what-is-tb500" className="mb-10"><h2 className="text-2xl font-bold mb-4">What Is TB-500?</h2><p className="text-muted-foreground mb-4 leading-relaxed">TB-500 is a synthetic version of Thymosin Beta-4, a 43 amino acid peptide naturally found throughout the body. It plays a role in tissue repair, cell migration, and blood vessel formation.</p></section>
          <section id="mechanism" className="mb-10"><h2 className="text-2xl font-bold mb-4">Mechanism of Action</h2><ul className="list-disc list-inside text-muted-foreground space-y-2"><li>Binds to actin, regulating cell structure and movement</li><li>Promotes cell migration to injury sites</li><li>May recruit stem cells for tissue repair</li><li>Anti-inflammatory effects</li></ul></section>
          <section id="animal-studies" className="mb-10"><h2 className="text-2xl font-bold mb-4">Animal Studies on Tendon/Tissue Repair</h2><p className="text-muted-foreground mb-4 leading-relaxed">Animal studies show TB-500 (Thymosin Beta-4) promotes tissue repair in various models including cardiac, dermal, and some musculoskeletal tissues. Tendon-specific studies are limited compared to BPC-157.</p></section>
          <section id="human-evidence" className="mb-10"><h2 className="text-2xl font-bold mb-4">Human Evidence (None)</h2><p className="text-muted-foreground leading-relaxed">There are no published human clinical trials on TB-500 for tendon repair or any musculoskeletal injury. Some cardiac studies exist with Thymosin Beta-4, but these don't apply to tendon healing claims.</p></section>
          <section id="vs-bpc157" className="mb-10"><h2 className="text-2xl font-bold mb-4">TB-500 vs BPC-157 for Tendons</h2><p className="text-muted-foreground leading-relaxed">Both lack human trials. BPC-157 has more tendon-specific animal research. They work through different mechanisms. Comparing them is speculative without human data.</p></section>
          <section id="legal-status" className="mb-10"><h2 className="text-2xl font-bold mb-4">Legal Status</h2><ul className="list-disc list-inside text-muted-foreground space-y-2"><li>FDA Category 2: Cannot be compounded</li><li>WADA banned under S0</li><li>Only available through gray market</li></ul></section>
          <section id="primary-sources" className="mb-10"><h2 className="text-2xl font-bold mb-4">Primary Sources</h2><ul className="list-disc list-inside text-muted-foreground space-y-2"><li><a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener noreferrer" className="text-primary hover:underline">PubMed: Thymosin Beta-4 Studies</a></li><li><a href="https://www.wada-ama.org/en/prohibited-list" target="_blank" rel="noopener noreferrer" className="text-primary hover:underline">WADA: Prohibited List</a></li></ul></section>
          <section id="faq"><GuideFAQ items={faqItems} /></section>
          <BottomLineBox content="TB-500 shows tissue repair effects in animal studies but has zero human clinical trials for tendon injuries. It shares FDA Category 2 status and WADA ban with BPC-157. Claims about tendon healing are extrapolations from animal data, not proven human outcomes." />
          <RelatedGuides guides={relatedGuides} />
          <GuideCTA />
          <GuideDisclaimer />
        </article>
      </div>
    </GuideLayout>
  );
}
